Pesquisar | AC Mingle

NutrWellnessHub adicionou um novo artigo Art
2026-08-29 09:17:58 -

LumiMeds GLP1: Understanding Tirzepatide and GLP-1 Care
Introduction LumiMeds GLP1 is an web-based weight loss service that is medically supervised through the LumiMeds platform. The programme may include compounded semaglutide, compounded tirzepatide, or another medication chosen by a licensed healthcare provider, per the patient’s medical history and eligibility. These treatments are prescription medications, not...

0 Comentários 0 Compartilhamentos 110 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
atharv2711 adicionou um novo artigo Outro
2026-09-21 10:16:30 -

Tirzepatide API Market Size to Reach USD 8.80 Billion by 2034 at 17.9% CAGR | Market Share, Growth, Forecast & Outlook
According to a report by Intel Market Research, the global Tirzepatide API Market was valued at USD 1.86 billion in 2025, estimated at USD 2.35 billion in 2026, and projected to reach USD 8.80 billion by 2034, representing a 17.9% CAGR during 2026–2034. The market covers pharmaceutical-grade tirzepatide active pharmaceutical ingredient used in regulated finished-dose manufacturing, while...

0 Comentários 0 Compartilhamentos 24 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Rutujad adicionou um novo artigo Outro
2026-09-22 09:19:54 -

GLP-1 Agonists Weight Loss Drugs Market Demand for Convenient Treatment Options
The weight management industry is moving through a major shift as pharmaceutical treatments become an increasingly visible part of obesity care. GLP-1-based medicines have moved from being primarily associated with metabolic disease management to becoming a major category within weight loss treatment, supported by rising obesity prevalence, clinical efficacy, greater awareness, and expanding...

0 Comentários 0 Compartilhamentos 10 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!